Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-15 07:45 am Unchanged | 13G | TOURMALINE BIO INC TRML | PFIZER INC PFE | 1,272,214 4.96% | 0 (Unchanged) | View |
| 2024-02-14 9:08 pm Purchase | 13G | TOURMALINE BIO INC TRML | Hydra LLC | 1,702,164 6.6% | 500,000 (+41.59%) | View |
| 2024-02-14 8:51 pm Purchase | 13G | TOURMALINE BIO INC TRML | Blue Owl Capital Holdings LP | 1,332,302 6.55% | 1,332,302 (New Position) | View |
| 2024-02-14 5:04 pm Unchanged | 13G | TOURMALINE BIO INC TRML | RA CAPITAL MANAGEMENT L.P. | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 4:57 pm Purchase | 13G | TOURMALINE BIO INC TRML | CITADEL ADVISORS LLC | 2,265 0% | 2,265 (New Position) | View |
| 2024-02-09 5:24 pm Unchanged | 13G | TOURMALINE BIO INC TRML | Blackstone Holdings II L.P. | 0 0% | 0 (Unchanged) | View |
| 2024-02-09 4:22 pm Purchase | 13G | TOURMALINE BIO INC TRML | TCG Crossover GP I LLC | 1,477,593 5.9% | 1,477,593 (New Position) | View |
| 2024-02-07 2:11 pm Purchase | 13G | TOURMALINE BIO INC TRML | BML Investment Partners L.P. | 245,500 1% | 245,500 (New Position) | View |
| 2023-11-06 4:30 pm Purchase | 13G | TOURMALINE BIO INC TRML | Hydra LLC | 1,202,164 5.9% | 1,202,164 (New Position) | View |
| 2023-10-30 5:16 pm Purchase | 13D | TOURMALINE BIO INC TRML | Longitude Capital Partners III LLC | 322,077 1.6% | 322,077 (New Position) | View |
| 2023-10-30 4:15 pm Purchase | 13D | TOURMALINE BIO INC TRML | Qiming U.S. Healthcare GP II LLC | 646,770 3.2% | 646,770 (New Position) | View |
| 2023-10-27 4:02 pm Purchase | 13G | TOURMALINE BIO INC TRML | Deep Track Capital LP | 1,815,854 8.93% | 1,815,854 (New Position) | View |
| 2023-10-27 4:01 pm Purchase | 13G | TOURMALINE BIO INC TRML | PFIZER INC PFE | 1,272,214 6.26% | 1,272,214 (New Position) | View |
| 2023-07-06 4:32 pm Purchase | 13G | TALARIS THERAPEUTICS INC TALS | RA CAPITAL MANAGEMENT L.P. | 2,333,175 5.5% | 2,333,175 (New Position) | View |
| 2023-04-27 2:19 pm Unchanged | 13G | TALARIS THERAPEUTICS INC TALS | BML Investment Partners L.P. | 2,189,193 5.2% | 0 (Unchanged) | View |
| 2023-04-27 10:55 am Purchase | 13G | TALARIS THERAPEUTICS INC TALS | BML Investment Partners L.P. | 2,189,193 5.2% | 2,189,193 (New Position) | View |
| 2023-02-14 08:02 am Sale | 13G | TALARIS THERAPEUTICS INC TALS | CITADEL ADVISORS LLC | 3,522,174 8.4% | -289,465 (-7.59%) | View |
| 2022-08-09 4:02 pm Sale | 13G | TALARIS THERAPEUTICS INC TALS | BlackRock Inc. BLK | 1,984,303 4.8% | -411,162 (-17.16%) | View |
| 2022-02-28 4:03 pm Purchase | 13D | TALARIS THERAPEUTICS INC TALS | Qiming U.S. Healthcare GP II LLC | 2,983,398 7.2% | 2,983,398 (New Position) | View |
| 2022-02-14 5:01 pm Unchanged | 13G | TALARIS THERAPEUTICS INC TALS | VIKING GLOBAL INVESTORS LP | 3,289,617 8% | 0 (Unchanged) | View |